Stop guessing and do some research then. Deals take time do they? That really is a fantastic insight and I hope Nina and the team have taken note and sprung into action.....
Oh wait, Nina already advised 12 months ago that DXB have received MULTIPLE material OFFERS for various territories:
INVESTOR BRIEFING NOTICE
MELBOURNE, Australia, 22 March 2023: Dimerix Limited (ASX: DXB) a biopharmaceutical
company with late-stage clinical assets in inflammatory diseases, is pleased to advise that CEO &
Managing Director, Dr Nina Webster, will be presenting at the Emergence23 Wholesale Investor
conference in Sydney on 24 March 2023.
Key points that will be covered:
• Phase 3 global clinical trial in FSGS kidney disease patients status and update
• Advanced partnering negotiations with material offers received from multiple parties for
various territories1
• Commercial opportunity and addressable market value.
The TH & announcement of the US licensing deal could be any day.......tick....tock...
Stop guessing and do some research then. Deals take time do...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.015(4.48%) |
Mkt cap ! $195.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.3¢ | 33.5¢ | $2.603M | 7.398M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 481759 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 132818 | 4 |
View Market Depth
| Last trade - 12.31pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
35.0¢ |
Change
0.015 ( 4.35 %) |
||||
| Open | High | Low | Volume | ||
| 33.5¢ | 36.5¢ | 33.5¢ | 4130274 | ||
| Last updated 12.39pm 03/05/2024 ? | |||||
| DXB (ASX) Chart |